Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB088508

Latexin Antibody (101), FITC, Novus Biologicals™
SDP

Catalog No. NB088508 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB088508 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB088508 Supplier Novus Biologicals Supplier No. NBP289341F
Add to Cart
Add to Cart

Description

Rabbit Monoclonal Antibody

Latexin Monoclonal specifically detects Latexin in Human samples. It is validated for Flow Cytometry, ELISA, Immunocytochemistry/Immunofluorescence.

Specifications

Antigen Latexin
Applications Flow Cytometry, ELISA, Immunofluorescence
Classification Monoclonal
Clone 101
Conjugate FITC
Formulation PBS
Gene Alias ECIMUM, Endogenous carboxypeptidase inhibitor, latexin, TCIProtein MUM, Tissue carboxypeptidase inhibitor
Host Species Rabbit
Immunogen This antibody was obtained from a rabbit immunized with purified, recombinant Human Latexin (NP_064554.3; Glu 2-Glu 222) .
Purification Method Protein A purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Immunology, Innate Immunity
Primary or Secondary Primary
Gene ID (Entrez) 56925
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.